Background Effective decongestion is a key therapeutic goal during hospitalisation for acute heart failure (HF), but the ...
For more than two decades, the crucial dilemma of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has remained unchanged: the same therapies used to treat myocardial ...
Background Nationwide studies report the high incidence of major health outcomes following myocardial infarction (MI). This ...
Background Pericarditis may be associated with significant morbidity and mortality and can be a clinically challenging entity ...
Pericarditis remains a clinical diagnosis. No single symptom, biomarker, electrocardiographic pattern or imaging finding is sufficiently sensitive and specific across the full spectrum of disease. The ...
Background Obesity is a major contributor to cardiovascular disease (CVD). Different fat depots may have distinct effects on ...
In the early 2000s, the natural history of heart failure (HF) was vividly illustrated, highlighting a defining feature of HF progression: a prolonged course of fluctuating yet steadily worsening ...
Background Proteomic biomarkers have shown promise in predicting various cardiovascular conditions, but their utility in assessing the risk of atrial fibrillation (AF) remains unclear. This study ...
Background Hypochloraemia has emerged as a prognostic marker in heart failure, although the mechanisms underlying chloride ...
Correspondence to Dr Niket Patel, Cardiology Department, Royal Free Hospital, Pond Street, London NW3 2QG, UK; niketpatel{at}nhs.net To understand the evolution in the strategies for the treatment of ...
7 WA Centre for Rural Health, University of Western Australia, Perth, Australia Correspondence to Karice K Hyun, The George Institute for Global Health, Sydney Medical School, University of Sydney, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results